Rep. Wiley Nickel

Maddy summaryHR 7555, the RETRO GSP Act, requires the U.S. government to refund over $3 billion in tariffs paid by American businesses on imports from beneficiary countries during the GSP program's lapse (Dec 31, 2020-enactment date). It directs U.S. Customs to retroactively treat qualifying import entries as if they occurred on Dec 31, 2020, allowing businesses to get tariff refunds. Companies must submit refund requests to Customs within 180 days of the bill's enactment, with payments due within 90 days of processing. This directly affects U.S. importers of goods from GSP-eligible countries who paid duties during the program's suspension.

Maddy summaryThe MATCH IT Act of 2024 establishes national standards to improve patient matching accuracy in electronic health records. It requires the Secretary to create a uniform definition for measuring patient match rates (accounting for duplicate/overlaid records) and develop a minimum data set to support 99.9% matching accuracy by healthcare systems. The bill mandates incorporating this data set into health IT certification requirements and Medicare interoperability programs within 18-24 months. It also creates a voluntary Medicare bonus for providers meeting 90% patient match rates, with anonymous reporting of accuracy data. This directly affects healthcare providers, health IT vendors, and Medicare participants by requiring standardized matching protocols to reduce medical errors and costs linked to misidentification.

Maddy summaryThis bill requires Medicare to provide clear outreach and education so Medicare beneficiaries (enrolled in Part A, Part B, or Medicare Advantage plans) can authorize family caregivers to access their health information via 1-800-MEDICARE. It mandates the inclusion of a specific authorization form (CMS-10106) in Medicare notices and on Medicare.gov, along with training for call center staff. The Secretary must also share best practices to prevent fraud related to caregiver access and make materials available in non-English languages. It directly affects beneficiaries, their family caregivers, healthcare providers, and Medicare call center operators.

Maddy summaryThis bill expands eligibility for certain tax-advantaged health accounts to cover medical expenses for parents. It amends the tax code to allow individuals to use funds from Health Savings Accounts (HSAs), Flexible Spending Accounts (FSAs), and Health Reimbursement Arrangements (HRAs) for qualified medical care of their parents or their spouse's parents - previously limited to immediate family members. The changes apply to expenses incurred after December 31, 2023, directly benefiting adult caregivers (like children supporting elderly parents) who use these accounts for parental healthcare costs. The bill makes no new funding commitments but adjusts existing account rules to reduce out-of-pocket costs for caregivers.

Maddy summaryThe Marriage Equality for Disabled Adults Act removes a rule requiring disabled adult children to remain unmarried to receive Social Security benefits. It ensures married disabled adult children, or their spouses, can maintain eligibility for Social Security Disability Insurance and Medicaid without losing benefits due to marriage. The bill changes how income and resources are counted, so a spouse's income and resources are no longer deemed against the disabled adult child for benefit calculations. It also requires states to preserve Medicaid eligibility for these individuals at the same level as if they were unmarried.

Maddy summaryHR 6465, the PLASMA Act, amends Medicare Part D's discount program to create a specific phase-in for plasma-derived specialty drugs. It directly affects Medicare Part D beneficiaries who use these drugs and reach their annual out-of-pocket spending limit. The bill establishes a new "specified plasma-derived product percent" to calculate discounted prices for these drugs, based on whether beneficiaries have already met their out-of-pocket threshold for other Part D drugs. This changes how manufacturers' negotiated prices are discounted for plasma-derived products under the existing program, without creating new benefits or altering coverage.

Maddy summaryThe ARCC Act provides $100 million in federal funding to help apprentices and pre-apprentices in job training programs cover childcare costs. It authorizes competitive grants to 10 states, which must distribute monthly stipends of at least $500 per dependent child directly to eligible childcare providers on behalf of participants in these programs. The bill prioritizes individuals from historically underrepresented groups (based on race, ethnicity, or gender) and ensures stipends are tax-free while not affecting eligibility for other federal benefits. States must report on participation, program completion rates, and demographic data, with the Secretary later summarizing program impacts for Congress.

Maddy summaryThis bill updates Medicare physician payment rules to improve stability and accuracy. It raises the budget neutrality threshold from $20 million (pre-2025) to $53 million in 2025, with annual indexing after 2026, to prevent excessive payment adjustments. The bill requires the Medicare program to correct budget neutrality payments based on actual service utilization data (not estimates) starting in 2025, and mandates updating direct cost inputs (like staff wages and equipment prices) every 5 years. It also caps annual changes to the physician payment conversion factor at 2.5% to limit sudden payment shifts, directly affecting Medicare physicians and healthcare providers receiving these payments.

Maddy summaryThe DRA of 2023 adjusts Medicare payment rates for specific durable medical equipment (DME) items that were part of the 2021 competitive bidding program but for which no supplier contracts were finalized. It directly affects DME suppliers and Medicare beneficiaries by establishing a new 2024 payment formula: 90% of the adjusted payment amount plus 10% of the unadjusted fee schedule for eligible items. The bill also extends a temporary transition rule for non-rural areas through December 31, 2024, while delaying a regulatory change until 2025. These provisions aim to stabilize payments for DME items that did not transition to standard pricing under prior rules.

Maddy summaryThe ORPHAN Cures Act amends the Drug Price Negotiation Program under the Social Security Act to clarify how orphan drugs (medications for rare diseases affecting fewer than 200,000 people in the U.S.) are treated. It ensures that periods when a drug was designated as an orphan drug are excluded from the time calculation used to determine when the drug can no longer be excluded from price negotiations. The bill also updates the definition to allow a single drug to be designated for multiple rare diseases, rather than just one. This change provides clearer rules for manufacturers and the government regarding orphan drug exclusions in the program.